Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1613 1652 1654 1656
This examiner grants 72% of resolved cases
Naghmeh Nina Moazzami is an examiner in Tech Center 1600, operating in Art Unit 1613. She has 74 resolved cases, which offers a clear view of her examination patterns. The allowance rate for these cases is 73.0 percent, showing a high frequency of granted patents.
The interview lift for this examiner is 47.9 percent. This is a very high increase, suggesting that interviews are exceptionally effective at moving cases toward allowance compared to the 73.0 percent baseline. Applicants should prioritize direct communication with the examiner to address any rejections in Art Unit 1613.
The median days to allowance is 1124. This timeline reflects the typical duration for applications that successfully reach a grant. Given the 73.0 percent allowance rate, the 47.9 percent interview lift is a critical factor for practitioners to leverage when seeking an efficient and positive outcome.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18249379 | MEDIUM COMPOSITION INCLUDING ETHANOL FOR PRODUCTION OF 2,3-BUTANEDIOL FROM SYNTHETIC GAS AND 2,3-BUTANEDIOL PRODUCTION METHOD USING SAME | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17628908 | CLEANING AGENTS INCLUDING ENZYME | Final Rejection | Henkel AG & Co. KGaA |
| 17612504 | NOVEL CRISPR-CAS SYSTEMS AND USES THEREOF | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 17311108 | Protein Crystal Engineering Through DNA Hybridization Interactions | Final Rejection | NORTHWESTERN UNIVERSITY |
| 18557895 | GDF15 MARKER PANELS FOR EARLY DETECTION OF SEPSIS | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18976500 | MEMBRANE PROTEIN ACTIVITY MEASUREMENT METHOD | Non-Final OA | THE UNIVERSITY OF TOKYO |
| 18547629 | BACTERIAL DNA CYTOSINE DEAMINASES FOR MAPPING DNA METHYLATION SITES | Final Rejection | University of Washington |
| 18561823 | A METHOD AND SYSTEM FOR INTEGRATED AND CONTINUOUS VIRAL FILTRATION, CONCENTRATION AND BUFFER EXCHANGE | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18560153 | COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18904277 | Method for Preparing a Three-Dimensional Scaffold for Medical Use | Non-Final OA | ASKEL HEATHCARE LTD. |
| 18747728 | USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION | Non-Final OA | EAST CHINA NORMAL UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy